IMCD Expands in China with Daoqin Acquisition

IMCD N.V. (GB:0QVU) has released an update.

Pick the best stocks and maximize your portfolio:

IMCD N.V. has announced the acquisition of Daoqin, a prominent distributor of food and nutraceutical ingredients in China, to enhance its presence in the life science sector. This strategic acquisition, expected to close in the second quarter of 2025, aims to leverage Daoqin’s expertise to bolster IMCD’s capabilities and offerings in the Chinese market.

For further insights into GB:0QVU stock, check out TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.